Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience-Reference-Cited by-同舟云学术

Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience

Published:2014-08-12 Issue:1 Volume:21 Page:e44-e50
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Khair K.¹,Batty P.²,Riat R.¹,Bowles L.³,Burgess C.¹,Chen Y. -H.⁴,Hart D.⁵,Platton S.²,Pasi J.⁶,Liesner R.¹

Affiliation:

1. Haemophilia Centre; Great Ormond Street Hospital for Children NHS Foundation Trust; London UK

2. The Royal London Haemophilia Centre; Barts and The London School of Medicine and Dentistry; The Royal London Hospital; London UK

3. St Bartholome w's Hospital; Haemophilia Centre; Barts and The London School of Medicine and Dentistry; The Royal London Hospital; London UK

4. The Royal London Haemophilia Centre London; Barts and The London School of Medicine and Dentistry; QMUL; London UK

5. Barts and The London School of Medicine and Dentistry; Haematology; The Royal London Hospital; London UK

6. Barts and The London; Centre for Haematology ICMS; The Royal London Haemophilia Centre London; Barts and The London School of Medicine and Dentistry; QMUL; London UK

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12497/fullpdf

Reference13 articles.

1. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor;Sadler;J Thromb Haemost,2006

2. Treatment of von Willebrand disease;Mannucci;N Engl J Med,2004

3. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders;Mannucci;Blood,1988

4. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors’ Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology;Keeling;Haemophilia,2008

5. Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate);Stadler;Biologicals,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review;Journal of Blood Medicine;2023-03

2. Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin^®) in paediatric patients under 6 years of age with severe von Willebrand disease;BLOOD TRANSFUS-ITALY;2023

3. Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results;Blood;2022-07-14

4. Outcomes of long‐term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review;Haemophilia;2022-03-26

5. Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature;Blood Advances;2022-01-04